Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
Biomarker
|
disease |
BEFREE |
To the best of our knowledge, we present a novel mutation of PTRF from Saudi Arabia and our findings broaden the mutation spectrum of PTRF in the familial CGL4 phenotype.
|
25721873 |
2015 |
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
Biomarker
|
disease |
MGD |
Deletion of cavin genes reveals tissue-specific mechanisms for morphogenesis of endothelial caveolae.
|
23652019 |
2013 |
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
CausalMutation
|
disease |
CLINVAR |
Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.
|
20300641 |
2010 |
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
GeneticVariation
|
disease |
BEFREE |
We report novel PTRF mutations and detailed phenotypes of two male and three female patients with CGL4 belonging to two pedigrees of Mexican origin (CGL7100 and CGL178) and one pedigree of Turkish origin (CGL180).
|
20684003 |
2010 |
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
GeneticVariation
|
disease |
BEFREE |
Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.
|
20300641 |
2010 |
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.
|
19726876 |
2009 |
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.
|
19726876 |
2009 |
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
Biomarker
|
disease |
MGD |
Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance.
|
18840361 |
2008 |
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
Biomarker
|
disease |
CTD_human |
|
|
|
Lipodystrophy, Congenital Generalized, Type 4
|
0.830 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Familial generalized lipodystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Congenital generalized lipodystrophy, type 4 (CGL4) is a rare autosomal recessive disorder caused by mutations in caveolae-associated protein 1.
|
30476128 |
2019 |
Familial generalized lipodystrophy
|
0.400 |
GermlineCausalMutation
|
disease |
ORPHANET |
Bone Density in Patients With Berardinelli-Seip Congenital Lipodystrophy Is Higher in Trabecular Sites and in Type 2 Patients.
|
27894728 |
2019 |
Familial generalized lipodystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Here we present characteristic skeletal muscle imaging findings in four patients with genetically defined childhood-onset RMD caused by CAV3 mutations and in one patient with congenital generalized lipodystrophy type 4 with muscular dystrophy due to polymerase I and transcript release factor (PTRF) mutations, which may have caused secondary deficiency of caveolin-3.
|
30174172 |
2018 |
Familial generalized lipodystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Maladaptative Autophagy Impairs Adipose Function in Congenital Generalized Lipodystrophy due to Cavin-1 Deficiency.
|
27144934 |
2016 |
Familial generalized lipodystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Novel nonsense mutation in the PTRF gene underlies congenital generalized lipodystrophy in a consanguineous Saudi family.
|
25721873 |
2015 |
Familial generalized lipodystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The major genetic factors in the generalized forms of the lipodystrophies, particularly Congenital generalized lipodystrophy (CGL)-Berardinelli-Seip syndrome, are the AGPAT2, BSCL2, caveolin 1 (CAV1) and polymerase-I-and-transcriptrelease factor (PTRF) genes.
|
24152769 |
2014 |
Familial generalized lipodystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy.
|
24024685 |
2013 |
Familial generalized lipodystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4.
|
20638880 |
2011 |
Familial generalized lipodystrophy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Mutations in AGPAT2, BSCL2, CAV1, and PTRF have been reported in congenital generalized lipodystrophy and in LMNA, PPARG, AKT2, and PLIN1 in FPL.
|
21865368 |
2011 |
Familial generalized lipodystrophy
|
0.400 |
GermlineCausalMutation
|
disease |
ORPHANET |
In conclusion, mutations in PTRF result in a novel phenotype that includes generalized lipodystrophy with mild metabolic derangements, myopathy, cardiac arrhythmias, atlantoaxial instability, and pyloric stenosis.
|
20684003 |
2010 |
Familial generalized lipodystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.
|
20300641 |
2010 |
Familial generalized lipodystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, mutations in PTRF result in a novel phenotype that includes generalized lipodystrophy with mild metabolic derangements, myopathy, cardiac arrhythmias, atlantoaxial instability, and pyloric stenosis.
|
20684003 |
2010 |
Familial generalized lipodystrophy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Here, we identified PTRF mutations in 5 nonconsanguineous patients who presented with both generalized lipodystrophy and muscular dystrophy.
|
19726876 |
2009 |
Lipodystrophy
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Interaction of cavin-1/PTRF leucine zipper domain 2 and its congenital generalized lipodystrophy mutant with model membranes.
|
31706570 |
2020 |
Lipodystrophy
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
We identified two new PTRF homozygous mutations (p.Asp59Val or p.Gln157Hisfs*52) in four patients with CGL4 presenting with generalized lipoatrophy and associated metabolic abnormalities.
|
27144934 |
2016 |